These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 21029240)

  • 21. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP; Piddlesden S; Morgan BP; Reynolds R
    Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination.
    Rodriguez EG; Wegner C; Kreutzfeldt M; Neid K; Thal DR; Jürgens T; Brück W; Stadelmann C; Merkler D
    Acta Neuropathol; 2014 Aug; 128(2):231-46. PubMed ID: 24563023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
    van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
    Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
    Skripuletz T; Lindner M; Kotsiari A; Garde N; Fokuhl J; Linsmeier F; Trebst C; Stangel M
    Am J Pathol; 2008 Apr; 172(4):1053-61. PubMed ID: 18349131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Meningeal T and Plasma Cell Infiltration is Associated with Early Subpial Cortical Demyelination in Common Marmosets with Experimental Autoimmune Encephalomyelitis.
    Kramann N; Neid K; Menken L; Schlumbohm C; Stadelmann C; Fuchs E; Brück W; Wegner C
    Brain Pathol; 2015 May; 25(3):276-86. PubMed ID: 25041171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
    J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.
    Clarner T; Diederichs F; Berger K; Denecke B; Gan L; van der Valk P; Beyer C; Amor S; Kipp M
    Glia; 2012 Oct; 60(10):1468-80. PubMed ID: 22689449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of system x
    Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
    J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The histopathology of grey matter demyelination in multiple sclerosis.
    Bø L
    Acta Neurol Scand Suppl; 2009; (189):51-7. PubMed ID: 19566500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.
    Silvestroff L; Bartucci S; Pasquini J; Franco P
    Exp Neurol; 2012 May; 235(1):357-67. PubMed ID: 22421533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Nikić I; Merkler D; Sorbara C; Brinkoetter M; Kreutzfeldt M; Bareyre FM; Brück W; Bishop D; Misgeld T; Kerschensteiner M
    Nat Med; 2011 Apr; 17(4):495-9. PubMed ID: 21441916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glial reactions and degeneration of myelinated processes in spinal cord gray matter in chronic experimental autoimmune encephalomyelitis.
    Wu J; Ohlsson M; Warner EA; Loo KK; Hoang TX; Voskuhl RR; Havton LA
    Neuroscience; 2008 Oct; 156(3):586-96. PubMed ID: 18718511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological findings in rats with experimental allergic encephalomyelitis.
    Dong M; Liu R; Guo L; Li C; Tan G
    APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.
    Peterson JW; Bö L; Mörk S; Chang A; Trapp BD
    Ann Neurol; 2001 Sep; 50(3):389-400. PubMed ID: 11558796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis.
    Gray E; Thomas TL; Betmouni S; Scolding N; Love S
    Brain Pathol; 2008 Jan; 18(1):86-95. PubMed ID: 18042261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis.
    Lagumersindez-Denis N; Wrzos C; Mack M; Winkler A; van der Meer F; Reinert MC; Hollasch H; Flach A; Brühl H; Cullen E; Schlumbohm C; Fuchs E; Linington C; Barrantes-Freer A; Metz I; Wegner C; Liebetanz D; Prinz M; Brück W; Stadelmann C; Nessler S
    Acta Neuropathol; 2017 Jul; 134(1):15-34. PubMed ID: 28386765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis.
    Amadio S; Montilli C; Magliozzi R; Bernardi G; Reynolds R; Volonté C
    Cereb Cortex; 2010 Jun; 20(6):1263-73. PubMed ID: 19783848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.